Novartis(NOVN.S)saidonMondayitplanstobuyAveXis(AVXS.O)for$218pershareinacashdealtotaling$8.7billionastheSwissdrugmakeraddsacompanywhosetopdrughopeful,forspinalm
GlaxoSmithKlineisbuyingNovartisoutoftheirconsumerhealthcarejointventurefor$13billion,takingfullcontrolofproductsincludingSensodynetoothpaste,Panadolheadachetabl